• General Dermatology
  • Eczema
  • Chronic Hand Eczema
  • Alopecia
  • Aesthetics
  • Vitiligo
  • COVID-19
  • Actinic Keratosis
  • Precision Medicine and Biologics
  • Rare Disease
  • Wound Care
  • Rosacea
  • Psoriasis
  • Psoriatic Arthritis
  • Atopic Dermatitis
  • Melasma
  • NP and PA
  • Skin Cancer
  • Hidradenitis Suppurativa
  • Drug Watch
  • Pigmentary Disorders
  • Acne
  • Pediatric Dermatology
  • Practice Management
  • Prurigo Nodularis

Video

The Hidden Costs of Atopic Dermatitis

Author(s):

Miranda Hester
Conference|Revolutionizing Atopic Dermatitis

Korey Capozza, MPH, the founder and executive director of Global Parents for Eczema Research expands on her talk from the 4th annual Revolutionizing Atopic Dermatitis (RAD) conference is held from April 9 to 11 in Baltimore, Maryland.

Korey Capozza, MPH, the founder and executive director of Global Parents for Eczema Research, describes how the costs of eczema for many family is beyond medication expenses.

Related Videos
1 KOL is featured in this series.
1 KOL is featured in this series.
1 KOL is featured in this series.
1 KOL is featured in this series.
Elizabeth Kiracofe, MD, FAAD, and Jenny Murase, MD, experts on atopic dermatitis
Elizabeth Kiracofe, MD, FAAD, and Jenny Murase, MD, experts on atopic dermatitis
Related Content
Delphi Study Offers Insights on Food Allergy Testing in AD
November 21st 2024

Delphi Study Offers Insights on Food Allergy Testing in AD

The Cutaneous Connection: Intervening in AD Progression for Pediatric Patients
August 2nd 2024

The Cutaneous Connection: Intervening in AD Progression for Pediatric Patients

FRONTIER-2 Study Evaluates Safety and Efficacy of Tozorakimab in Patients with AD
November 19th 2024

FRONTIER-2 Study Evaluates Safety and Efficacy of Tozorakimab in Patients with AD

The Cutaneous Connection: Navigating Systemic Therapies in Atopic Dermatitis
July 1st 2024

The Cutaneous Connection: Navigating Systemic Therapies in Atopic Dermatitis

APP Insights Into AD Therapy: Systemics May Improve Patient Compliance
November 8th 2024

APP Insights Into AD Therapy: Systemics May Improve Patient Compliance

PDUFA Date for Tapinarof 1% Cream in Atopic Dermatitis Pushed to 2025
November 5th 2024

PDUFA Date for Tapinarof 1% Cream in Atopic Dermatitis Pushed to 2025

© 2024 MJH Life Sciences

All rights reserved.